Skip to main content
Log in

pH Dependent Binding of Ligands to Serum Lipoproteins

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The binding interactions of binedaline, nicardipine and darodipine with lipoproteins (HDL, LDL, VLDL) were examined as a function of pH in order to evaluate the role of lipoprotein components and ligand protonation in the binding process.

Methods. Binding studies were performed by equilibrium dialysis with radiolabeled ligands and differential UV-visible spectroscopy.

Results. Deprotonated ligands had a markedly higher affinity for lipoproteins than the protonated forms, resulting in a concomitant decrease in the pKa of bound ligands, i.e., a decrease in the basicity of the ligand in the bound state. The UV-visible difference spectra generated upon binding of auramine O to lipoproteins also showed that there was a contribution to the binding arising from the deprotonation of the ligand. Ligand binding was related to the phospholipid and cholesteryl ester content and to a lesser degree to the free cholesterol and protein content of lipoproteins, therefore to the surface monolayer components of lipoproteins. This relationship was even more accurate for the deprotonated, high-affinity, than for the protonated species.

Conclusions. It is suggested that among other possible interactions, ligand binding to lipoproteins involves proton exchange between the reactants and that the high affinity ligand species interact more specifically with the phospholipids of the lipoprotein surface monolayer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. J. P. Tillement, G. Houin, R. Zini, S. Urien, E. Albengres, J. Barré, M. Lecomte, P. D'Athis, and B. Sébille. Adv Drug Res 13:59–94 (1984).

    Google Scholar 

  2. J. C. Mazière, P. Morlière, and R. Santus. J Photochem Photobiol Biol 8:351–360 (1991).

    Google Scholar 

  3. S. Glasson, R. Zini, and J. P. Tillement. Biochem Pharmacol 31:831–835 (1982).

    Google Scholar 

  4. B. W. Shen, A. M. Scanu, and F. J. Kézdy. Proc Natl Acad Sci USA 74:837–841 (1977).

    Google Scholar 

  5. S. Urien, E. Albengres, R. Zini, and J. P. Tillement. Biochem Pharmacol 31:3687–89 (1982).

    Google Scholar 

  6. S. Urien, P. D'Athis, and J. P. Tillement. Biochem Pharmacol. 33:2283–89 (1984).

    Google Scholar 

  7. S. Urien, F. Brèe, B. Testa, and J. P. Tillement. Biochem J 280:277–280 (1991).

    Google Scholar 

  8. J. P. Corsetti, C. H. Weidner, J. Cianci, and C. E. Sparks. Anal Biochem 195:122–128 (1991).

    Google Scholar 

  9. L. A. Sklar, M. C. Doody, A. M. Gotto Jr, and H. J. Pownall. Biochemistry 19:1294–1301 (1980).

    Google Scholar 

  10. P. Greenspan and S. D. Fowler. J Lipid Res 26:781–789 (1985).

    Google Scholar 

  11. J. Y. C. Ma, J. K. H. Ma, and K. C. Weber. J Lipid Res 26:735–744 (1985).

    Google Scholar 

  12. R. Chelvi and C. D. Fitch. Antimicrob Agents Chemother 21:581–586 (1982).

    Google Scholar 

  13. G. A. Cutsforth, R. N. Whitaker, J. Hermans, and B. R. Lentz. Biochemistry 28:7453–7461 (1989).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simon, N., Dailly, E., Jolliet, P. et al. pH Dependent Binding of Ligands to Serum Lipoproteins. Pharm Res 14, 527–532 (1997). https://doi.org/10.1023/A:1012120104615

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012120104615

Navigation